BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Bot Chart, page-10600

  1. 2,054 Posts.
    lightbulb Created with Sketch. 1466
    It's pretty clear, to the rest of the entire investing world, that the FDA's Complete Response Letter was not a 'rejection' of Sofdra, but rather was "the FDA will approve Sofdra when BOT fix some minor instruction issues and labelling". Everybody knows that!
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.